Search Results 61-70 of 14722 for alt

1. S1400 Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer - Mayo Clinic

   ... ALT or AST must be =< 5 x IULN (if both ALT and AST are done, both must be =< 5 x IULN); Serum creatinine =< the IULN OR measured or calculated creatinine ...

2. Biliary atresia - Diagnosis and treatment - Mayo Clinic

   Mildly elevated aspartate aminotransferase (AST) and alanine aminotransferase (ALT), which are liver enzymes. Matrix metalloproteinase-7 (MMP7) testing.

3. Saroglitazar Magnesium for Treatment of Primary Biliary Cholangitis - Mayo Clinic

   ALT or AST > 250 U/L 17. Participation in another interventional clinical study and receipt of any other investigational medication (within 12 weeks prior ...

4. Biliary atresia - Symptoms and causes - Mayo Clinic

   Alanine aminotransferase (ALT) blood test · Aspartate aminotransferase (AST) blood test · Bilirubin test · HIDA scan · Liver biopsy · Liver transplant ...

5. A Study Of NST-6179 In Subjects With Intestinal Failure-Associated Liver Disease (IFALD). - Mayo Clinic

   ALT and AST \<5 × ULN; 2. Total bilirubin ≤2.5 mg/dL in the absence of Gilbert's Syndrome. 3. Serum albumin ≥2.5 g/dL; 4. International normalized ratio ...

6. Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma - Mayo Clinic

   * Serum glutamate pyruvate transaminase (SGPT) (ALT) =< 225 U/L (=< 5x ULN) (within 7 days prior to enrollment), and. * Note: For the purpose of this study ...

7. A Study of How Common Bile Acid Malabsorption is in Patients with Diarrhea Predominant Irritable Bowel Syndrome - Mayo Clinic

   If there are no AST or ALT values in the medical record, the study physicians will determine if the tests need to be run. Participating Mayo Clinic locations.

8. A Study to Evaluate At Home Administration of Pertuzumab Combined with Trastuzumab to Treat Patients with HER2-Positive Breast Cancer During COVID-19 Pandemic - Mayo Clinic

   ... (ALT) levels as defined below: Patients with early breast cancer: AST and ALT > 1.5 x ULN;; Patients with metastatic breast cancer: AST and ALT > 2.5 x ULN; ...

9. An Open Label Extension Study of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet or Lennox-Gastaut Syndromes - Mayo Clinic

   ALT or AST > 5 × upper limit of normal (ULN); · ALT or AST > 3 × ULN and (TBL > 2 × ULN or INR > 1.5); · ALT or AST > 3 × ULN with the presence of fatigue, nausea ...

10. Publications - Lilly H. Wagner, M.D. - Mayo Clinic

    ... Alt E. CXCR4 receptor positive spheroid forming cells are responsible for tumor invasion in vitro. Cancer Lett. 2009 Jul 18; 280 (1):65-71 Epub 2009 Mar 14